5 Best Micro Cap Stocks To Invest In

3. KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)

Number of Hedge Fund Investors In Q2 2023: 23

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is a biotechnology company that develops treatments for diseases such as diabetes complications and skin system disorders. Its shares are rated Strong Buy on average, and analysts have set an average share price target of $20.67.

By the end of 2023’s second quarter, 23 out of the 910 hedge funds polled by Insider Monkey had owned a stake in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV). Kevin C. Tang’s Tang Capital Management is the biggest shareholder among these through its $23.8 million stake.

Follow Kalvista Pharmaceuticals Inc. (NASDAQ:KALV)